MARKET

PCRX

PCRX

Pacira Biosciences Inc
NASDAQ
25.87
-0.48
-1.82%
After Hours: 25.51 -0.36 -1.39% 19:38 09/08 EDT
OPEN
25.98
PREV CLOSE
26.35
HIGH
26.41
LOW
25.68
VOLUME
386.42K
TURNOVER
--
52 WEEK HIGH
27.66
52 WEEK LOW
18.80
MARKET CAP
1.03B
P/E (TTM)
74.53
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at PCRX last week (0831-0904)?
Weekly Report · 1d ago
How Pacira’s Post‑Divestiture Earnings Beat And Expense Shift At Pacira BioSciences (PCRX) Has Changed Its Investment Story
Simply Wall St · 4d ago
Weekly Report: what happened at PCRX last week (0824-0828)?
Weekly Report · 08/31 09:17
Weekly Report: what happened at PCRX last week (0817-0821)?
Weekly Report · 08/24 09:17
Analyst Initiates Buy on Pacira, Citing Durable Exparel Growth and Pipeline Upside with $30 Price Target
TipRanks · 08/17 12:17
Pacira reinstated with a Buy at Truist
TipRanks · 08/17 10:45
Weekly Report: what happened at PCRX last week (0810-0814)?
Weekly Report · 08/17 09:17
Pacira BioSciences (PCRX) Is Down 7.1% After Advancing PCRX-201 Gene Therapy With Positive Phase 1 Data
Simply Wall St · 08/10 12:31
More
About PCRX
Pacira BioSciences, Inc. is the holding company for its subsidiary, Pacira Pharmaceuticals, Inc. The Company has three commercial-stage non-opioid treatments: EXPAREL (bupivacaine liposome injectable suspension), a long-acting local analgesic approved for infiltration, fascial plane block, and as an interscalene brachial plexus nerve block, an adductor canal nerve block, and a sciatic nerve block in the popliteal fossa for postsurgical pain management; ZILRETTA (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular injection indicated for the management of osteoarthritis knee pain, and iovera, a handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. The Company is also advancing the development of PCRX-201, a locally administered gene therapy with the potential to treat largely prevalent diseases like osteoarthritis.

Webull offers Pacira Biosciences Inc stock information, including NASDAQ: PCRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PCRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PCRX stock methods without spending real money on the virtual paper trading platform.